Skip to content

Bio-Techne TECH Ratios & Valuation

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
Profitability
Gross margin65%-0.8pp65.2%-0.4pp65.4%-0.1pp64.8%-1.6pp65.8%-1.0pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio4.5×+0.8×4.5×+0.6×4.2×-0.3×3.5×-0.4×3.7×-0.4×
Leverage
Debt-to-equity0.1×-0.1×0.2×0.0×0.2×0.0×0.2×0.0×
Per Share
Book value per share$13.25+4.3%$12.81-1.0%$12.01-6.6%$12.70+1.2%
Valuation
Market capitalization$8.18B-11.8%$9.16B-19.9%$8.66B-31.4%$7.84B-30.5%$9.27B-16.3%
Price / sales6.8×-0.9×7.5×-2.0×7.1×-3.7×6.4×-3.3×7.7×-1.9×
Price / book3.9×-0.7×4.6×-0.9×4.1×-1.4×4.6×-0.9×
Dividend yield0.6%+0.1pp0.5%+0.1pp0.6%+0.2pp0.6%+0.2pp0.5%+0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bio-Techne's profit margins?
Bio-Techne (TECH) runs a 65.0% gross margin and a 14.2% operating margin, with a 10.9% net margin.
Where do Bio-Techne's ratios come from?
Every ratio is computed from Bio-Techne's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.